| Literature DB >> 31770441 |
Drew Provan1, Donald M Arnold2, James B Bussel3, Beng H Chong4, Nichola Cooper5, Terry Gernsheimer6, Waleed Ghanima7,8, Bertrand Godeau9, Tomás José González-López10, John Grainger11, Ming Hou12, Caroline Kruse13, Vickie McDonald14, Marc Michel9, Adrian C Newland1, Sue Pavord15, Francesco Rodeghiero16, Marie Scully17, Yoshiaki Tomiyama18, Raymond S Wong19, Francesco Zaja20, David J Kuter21.
Abstract
Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. A critical review was performed to identify all relevant articles published between 2009 and 2018. An expert panel screened, reviewed, and graded the studies and formulated the updated consensus recommendations based on the new data. The final document provides consensus recommendations on the diagnosis and management of ITP in adults, during pregnancy, and in children, as well as quality-of-life considerations.Entities:
Mesh：
Year: 2019 PMID： 31770441 PMCID： PMC6880896 DOI： 10.1182/bloodadvances.2019000812
Source DB: PubMed Journal: Blood Adv ISSN： 2473-9529